Hemophilia Fighter Bioverativ Launches On NASDAQ
February 02, 2017 at 15:41 PM EST
Bioverativ Inc (NASDAQ: BIVVV) — the NASDAQ's brand-new biotech company that’s focused on treatments for hemophilia and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.